Adopted MeasuresDeveloping MeasuresStanding WorkgroupsResourcesBibliography
Policy Commitee

 

Chair: Frank McCorry, Ph.D. is the Director of the New York City Office of the Commissioner for the New York State Office of Alcoholism and Substance Abuse Services. He is responsible for clinical policy and practice improvement issues, particularly in the areas of public health, co-occurring mental health and addictive disorders and managed care. He represents OASAS on a joint initiative with the Office of Mental Health on co-occurring disorders, which is based on the “New York Model,” a conceptual paradigm for the treatment of persons with co-occurring disorders. Dr. McCorry also oversees the development of new initiatives that respond to emerging issues like improving patient outcomes through the adoption of evidence-based interventions. He is the Principal Investigator on the National Institute on Drug Abuse State Infrastructure Grant to enhance the state’s capacity to foster the adoption of evidence-based practices, and a Robert Wood Johnson Foundation grant to improve access and retention through the use process improvement approaches. Dr. McCorry is Chairperson of the Washington Circle Group, a SAMHSA-sponsored initiative to develop substance abuse performance measures for use in managed care and public sector settings. He is co-Chair of the National Quality Forum’s Evidence-based Practices to Treat Substance Use Disorders Steering Committee. He is a member of SAMHSA’s Center for Substance Abuse Treatment’s National Advisory Council. He also serves on the Editorial Board of the Journal of Substance Treatment and the External Advisory Board of the Brandeis/Harvard Center on Managed Care. Dr. McCorry has worked in the field of substance abuse prevention and treatment for over 30 years. He received his doctorate in Counseling and Human Services from St. John’s University in 1982.


Joann Albright, Ph.D.is Senior Vice President of Quality, Outcomes and Research at Magellan Health Services, directing its the quality, outcomes and research programs.  Magellan Health Services is a specialty services managed care company providing behavioral health management, radiology management and specialty pharmacy management services.  Dr. Albright leads a national team in policy and standard development, quality operations, survey and evaluation procedures, patient safety enhancement, and in the development and monitoring of performance and outcomes measures. Dr. Albright coordinates research initiatives with academic institutions designed to translate research into practice. Dr. Albright received her Ph.D. in psychology from the University of Denver and is a licensed psychologist.  She has authored or served as project director for nine national grants, conducted research on brief therapy and has clinical experience in inpatient, outpatient and university treatment settings. Dr. Albright has twenty-five years of clinical experience, ten of which have been in managed care directing clinical, quality and outcomes programs.
Back to top


John Bartlett M.D. M.P.H.is a Yale and UCLA-trained psychiatrist and manager and a widely respected thinker and visionary on the management and improvement of behavioral healthcare, particularly through the design and development of effective organizational capabilities and infrastructure. He is currently a principal with the Avisa Group, a consulting firm with expertise in policy formulation and program development in behavioral healthcare. In addition to his work with the Avisa Group, Dr. Bartlett currently serves as the executive director of the Forum on Performance Measures in Behavioral Healthcare, a national public policy group devoted to the improvement of treatment and service delivery in behavioral healthcare and prevention through the development and implementation of effective and efficient approaches to accountability and improvement. He also serves as a member of the Policy Committee of the Washington Circle Group, which seeks to improve substance abuse treatment and prevention through the development and dissemination of addiction-specific standards and measures. Dr. Bartlett has extensive experience in both the public and private sectors. Following the completion of his training at UCLA, where he was a Robert Wood Johnson Clinical Scholar and received a MPH in Health Services Management from the UCLA School of Public Health, Dr. Bartlett worked as the Assistant Chief of Staff at the Wadsworth VA Medical Center. In the private sector he has held a number of senior level positions, including that of executive vice president for clinical strategies at Magellan Health Services, currently the nation’s largest managed behavioral healthcare organization; corporate medical director of MCC Behavioral Care, a CIGNA subsidiary; and regional medical director for CIGNA Private Practice Plan, an IPA-type HMO in southern California. In addition, Dr. Bartlett is active at the national level in a variety of roles. These include his past chairmanship of the Quality Improvement and Clinical Services Committee of the American Managed Behavioral Healthcare Association, where for three years he led the development of PERMS, the association's set of performance measures for managed behavioral healthcare programs. Dr. Bartlett also serves as a member of the Behavioral Measures Advisory Panel of the National Committee for Quality Assurance and as a member of the Technical Advisory Panel for the National Quality Forum’s initiative on evidence-based practices for substance use disorder treatment.
Back to top


Rhonda J. Robinson Beale, M.D.is Chief Medical Officer of United Behavioral Health (UBH), where she is responsible for facilitating the clinical direction, quality of care and clinical policy of the organization. Prior to coming to UBH she was the Chief Medical Officer for PacifiCare Behavioral Health prior to its acquisition by UBH. Dr. Robinson Beale has been very active with national organizations and initiatives involving quality. She is currently a member of the Institute of Medicine Health Services Board and is serving on an IOM study examining psychosocial services need for cancer patients due to be published later this year. She has also served on the IOM Neuroscience and Behavioral Health Board. Other important work with the IOM included work on the IOM committee which produced the national studies, “To Err is Human” and “Crossing the Quality Chasm.”  She was a co-author of the IOM’s “Managing Managed Care Quality Improvement in Behavioral Health” study in 1997. Dr Robinson Beale is currently co-chairing a National Quality Forum Steering Committee working on “Evidence-Based Practices to Treat Substance Use Conditions’. She was also on the Technical Advisory Committee to review behavioral health Ambulatory standards. She has also been a member of NCQA’s Review Oversight Committee for six years and was a member of the Behavioral Medicine Subcommittee that wrote and refined the behavioral medicine standards for health care businesses.  She is currently serving on the IOM Health Services Board. During the last 10 years, she has presented extensively on a variety of quality and care management themes.  Before joining UBH, Dr. Robinson Beale was with CIGNA Behavioral Health in 2002 as the Chief Medical Officer. She was also at Blue Cross Blue Shield of Michigan as its National Medical Director and Medical Director over disease, and case management and their nurse call in line for their indemnity product.  Prior to that, she was Health Alliance Plan’s (HAP) Senior Medical Director - Behavioral Medicine where she helped design their behavioral health managed care system. Dr. Robinson Beale has over 30 years of private practice experience in general psychiatry and, substance abuse particularly drug addicted mothers. She completed her M.D. training at Wayne State University School of Medicine in 1975 and interned at Detroit’s Hutzel Hospital, completing her residency at the Detroit Psychiatric Institute.
Back to top


Elaine F. Cassidy, Ph.D.is a Program Officer in Research and Evaluation at the Robert Wood Johnson Foundation, where she works on grant-making related to Addiction Prevention and Treatment and Vulnerable Populations. Her work and interests focus primarily on child and adolescent health and risk behaviors, violence prevention, and school-based interventions, particularly for children and adolescents living in low-income, urban environments. Cassidy is a former school psychologist and trained mental health clinician, who has provided therapeutic care to children and families in school, outpatient and acute partial hospitalization settings. Cassidy holds a B.A. in Psychology and Liberal Studies from the University of Notre Dame, an M.S.Ed. in Psychological Services from the University of Pennsylvania, and a Ph.D. in School, Community, and Child-Clinical Psychology from the University of Pennsylvania.
Back to top


John Carnevale, Ph.D. is President of Carnevale Associates, LLC, a public policy firm that offers guidance to governments, organizations, and communities as they confront the public policy and program challenges of the 21st century. The firm is organized into three practice groups to provide value and insight to customers: Strategic Planning, Integrated Communications, and Policy Research and Data Analysis. Dr. Carnevale has served three administrations and four “Drug Czars” within the Executive Branch of the U.S. Government. At the White House Office of National Drug Control Policy (ONDCP), he directed the formulation of the President’s National Drug Control Strategy as well as the federal drug control budget. Dr. Carnevale is recognized as the key architect of the Performance Measures of Effectiveness (PME) System which ONDCP used to determine progress towards national goals and objectives. He is also credited with directing policy research that shifted the primary focus of the Nation’s Drug Control Strategy from supply to demand reduction.
Back to top


Doreen Cavanaugh, Ph.D. is a Research Associate Professor at the Health Policy Institute, Georgetown Public Policy Institute, Georgetown University where she is responsible for conducting a program of research and policy analysis in the areas of child and adolescent mental health and substance abuse treatment. She is a Senior Advisor to the Center for Substance Abuse Treatment, (SAMHSA) on adolescent issues addressing the financing and organization of adolescent substance abuse treatment services as well as services for youth with co-occurring disorders. Dr. Cavanaugh is the National Program Director of a 16 state CSAT grant initiative to improve the state infrastructure supporting delivery of treatment for adolescents with substance use and co-occurring disorders. She served as Chairperson of the Financing Workgroup for the Center for Substance Abuse Treatment/Robert Wood Johnson Foundation Summit on Adolescent Substance Abuse Treatment and works on issues including financing treatment and program sustainability. She has completed an extensive analysis of federal policies affecting the delivery of treatment services for adolescents with substance use disorders, and has consulted on the organization and financing of child and adolescent treatment services for states, foundations and national organizations.  Dr. Cavanaugh is Co-chair of a CSAT sponsored committee developing a consumer perception of care survey for adolescents and adults receiving substance abuse treatment. She was the Co-chair of a joint CSAT/CMHS Child/Adolescent Modular Survey Committee and chaired the Washington Circle Subcommittee on Performance Measurement for Care of Adolescents with Substance Use Disorders, a Center for Substance Abuse Treatment supported national group of adolescent substance abuse treatment experts charged with assessing the applicability of the Washington Circle administrative measures to adolescent substance abuse treatment. She serves on a number of related committees including the CMHS sponsored Outcomes Roundtable for Children and Families. Currently Dr. Cavanaugh teaches Mental Health Policy at the Georgetown Public Policy Institute. She taught both Child Welfare Policy and Mental Health Policy at the Boston University School of Social Work for many years.  Dr. Cavanaugh received her Ph.D. in Social Policy from the Heller School for Social Policy and Management, Brandeis University.
Back to top


Mady Chalk, Ph.D. is the Director of the Center for Performance-Based Policy at the Treatment Research Institute (TRI) where she directs collaborations between and among researchers, state and local policy makers, purchasers, elected officials, and treatment providers to develop policy-based strategies to improve the delivery of addiction treatment.  A signature project at TRI is the Mutual Assistance Program for States (“MAPS”) where Dr. Chalk leads eight states working with researchers and policy experts to develop and evaluate projects to reform administrative and purchasing practices in addiction.  Prior to joining TRI, for many years Dr. Chalk was Director of the Division of Services Improvement in the Center for Substance Abuse Treatment (CSAT)/Substance Abuse and Mental Health Services Administration (SAMHSA). Dr. Chalk provided federal leadership for the discretionary grant program at CSAT and for its quality improvement programs, including the Washington Circle Group.  On behalf of CSAT she participated in NiaTx, implementation of the Center’s science-to-service/best practices agenda, its organization and financing studies, and workforce development activities. Dr. Chalk provided leadership for a number of innovative new State-wide programs related to increasing access to alcohol and drug treatment, including a program in general medical settings that provides screening, brief interventions, and referrals to treatment.  Before joining the federal government, Dr. Chalk was Senior Program Officer at the National Academy of Sciences, Institute of Medicine. She received her Ph.D. in Health and Social Policy from the Heller School at Brandeis University.  For 15 years before coming to the Washington area, Dr. Chalk was a faculty member in the Yale University School of Medicine, Department of Psychiatry, and the Director of the Outpatient /Community Services Division of Yale Psychiatric Institute.
Back to top


Dr. Sarah Duffy is a Health Scientist Administrator in the Services Research Branch (SRB), Division of Epidemiology, Services and Prevention Research, at the National Institute on Drug Abuse.  She is responsible for the economics research portfolio.  Prior to joining NIDA she spent eight years as a  research economist at the Office of Applied Studies, SAMHSA, where she used data from large national data collection projects, including the National Survey on Drug Use and Health (NSDUH) and Treatment Episode Data Set (TEDS), to conduct economic and health services research on substance abuse treatment and costs. Prior to joining SAMHSA, Dr. Duffy worked for the Maryland Health Services Cost Review Commission and the U.S. Agency for Healthcare Research and Quality where she conducted research using hospital cost report and discharge abstract data. She has published several articles in the substance abuse treatment, health services research, and economics literatures. She received her Ph.D. in economics from the University of North Carolina, Chapel Hill.
Back to top


Dr. Deborah Garnick is a Professor in the Institute for Behavioral Health at The Heller School for Social Policy and Management at Brandeis University and Associate Dean, Academic Personnel. She received her doctorate in health services research from the School of Hygiene and Public Health at Johns Hopkins University (now the Bloomberg School of Public Health). During the first ten years of her career, when Dr. Garnick’s research was focused on the quality of hospital services, she explored the issues of hospital market areas, patients’ decisions to select hospitals based on quality, and hospital outcomes. With colleagues at the University of California, she focused on the relationship of hospital volume and patient outcomes, then a newly emerging area of research. Currently, Dr. Garnick leads the Brandeis team in a collaboration with RTI focused on technical development of the National Outcome Measures (NOMS) for behavioral health in a project funded by the Substance Abuse and Mental Health Administration (SAMHSA). She has led NIH-funded studies focused on exploring the association between substance performance measures and outcomes. She serves as is the Co-Principal Investigator on studies that involve tracking of drug and alcohol abuse services and mental health services provided by the managed behavioral health care industry. In addition, she is a member of the Washington Circle Policy Group and leads their workgroup on public sector performance measures for substance abuse. Dr. Garnick often serves as an expert consultant, most recently as a member of the National Quality Forum’s Substance Use Disorders and Evidence Based-Practices Technical Advisory Panel. Dr. Garnick has published widely on the topics of injuries among Medicare and Medicaid beneficiaries, state-level health insurance reform legislation, quality of hospital and ambulatory care, methods of using data collected for administrative purposes for health services research, and performance measures for substance abuse.
Back to top


David R. Gastfriend, M.D. is Vice President for Medical Affairs at Alkermes, Inc. where he is involved in research, education and scientific publication on behalf of the company’s efforts in the field of addiction treatment.  For over two decades, he has served on the faculty of Harvard Medical School, most recently as Associate Professor of Psychiatry, and Director of the Addiction Research Program at Massachusetts General Hospital (MGH).  While there he founded the Fellowship in Addiction Psychiatry at the MGH and provided clinical care to substance abuse patients. One of the few physicians in the country to be certified both in Addiction Medicine by the American Society of Addiction Medicine and in Addiction Psychiatry by the American Board of Neurology and Psychiatry, Dr. Gastfriend has conducted studies of both pharmacologic and behavioral treatments of alcohol and drug use disorders.  He initiated the first multi-site study to validate and refine the Patient Placement Criteria published by the American Society of Addiction Medicine, for which he was funded for seven years by the National Institute on Drug Abuse.  In 2001, he was the recipient of a five-year Mid-Career Investigator Award for Patient-Oriented Research from NIDA, and in 2002 he was a nominee for the Robert Wood Johnson Foundation Award, “Innovators Combating Substance Abuse.”  Dr. Gastfriend was also a Co-Principal Investigator on the NIDA-funded Cocaine Collaborative Psychotherapy Study and the NIAAA collaborative study COMBINE. He chairs the Treatment Outcome Research Committee of the American Society of Addiction Medicine (ASAM), is a two-term elected Delegate-At-Large on ASAM’s Board, and also sits on the Board of the International Society of Addiction Medicine.  He serves on the editorial boards of both The Journal of Substance Abuse Treatment and The Journal of Addictive Diseases, and is Associate Editor of The Journal of Computers in Human Services.  He is co-editor of the leading book on treatment matching in the field, The ASAM Patient Placement Criteria for Substance-Related Disorders and editor of Addiction Treatment Matching. Dr. Gastfriend received a B.A. at Haverford College in Philadelphia, Pennsylvania and an M.D. from Jefferson Medical College in Philadelphia, Pennsylvania.
Back to top

Pamela Greenberg, M.P.P.is the President and CEO of the Association for Behavioral Health and Wellness (ABHW – formerly the American Managed Behavioral Healthcare Association).  ABHW is an association of the nation’s leading behavioral health and wellness companies.  These companies provide an array of services related to mental health, substance use, employee assistance, disease management, and other health and wellness programs to over 110 million people in both the public and private sectors.Greenberg serves on the Editorial Board of the Bureau of National Affairs Health Plan and Provider Report and BEHAVIORAL HEALTHCARE.  She also is the Chair of the Coalition for Fairness in Mental Illness Coverage and a member of:  the Mental Health Liaison Group Steering Committee, the Treatment/Recovery Information and Advocacy Database (TRIAD) Advisory Group, the Client Patient Sample Survey Technical Work Group, the DS 2000+ Oversight Committee, the Washington Circle Group Policy Committee and the National Advisory Board for the UPENN Rehabilitation Research and Training Center on Community Integration of People with Psychiatric Disabilities.  She was a member of the National Committee on Employer-Sponsored Behavioral Healthcare Services, the Adult Mental Health Workgroup within the Forum for Performance Measures for Mental Health and Substance Abuse Services, the Mental Health Statistics Improvement Program (MHSIP) Consumer Report Card Workgroup, the Experience of Care and Health Outcomes (ECHOTM) Survey Development Team, the Stakeholders Advisory Council for the Substance Abuse and Mental Health Services Administration (SAMHSA) Managed Care Tracking System on Behavioral Health, and the Technical Advisory Panel for the Evaluation of the Effects of the Vermont Parity Act.  Prior to joining ABHW Greenberg was the Deputy Director of Federal Affairs for America’s Health Insurance Plans (AHIP) and, earlier, a Legislative Assistant at Capitol Associates, a healthcare consulting firm in Washington, D.C.  Greenberg serves on several Boards and has a B.A. from Mount Holyoke College and a Masters in Public Policy from Georgetown University.
Back to top


David H. Gustafson, Ph.D. is Director of University of Wisconsin-Madison’s (UCW) Center of Excellence in Cancer Communications Research, funded by the National Cancer Institute, and Director of the Network for the Improvement of Addiction Treatment, jointly funded by the Robert Wood Johnson Foundation and the Center for Substance Abuse Treatment. He is a Research Professor of Industrial and Systems Engineering at UCW, where he is the Director of the Center for Health Enhancement Systems Studies. His research interests in decision, change, and information theory come together in the design and evaluation of computer-based health communication systems to help people cope with serious illness. Dr. Gustafson’s research focuses on the use of systems engineering methods and models in individual and organizational change applied to health and healthcare. His research on individual change centers on developing and evaluating eHealth systems using as the test vehicle CHESS (the Comprehensive Health Enhancement Support System), a computer system to help people facing serious health problems with a particular focus on cancer and risk taking behaviors. His randomized control trials and field tests of CHESS help understand acceptance, use, and impact of eHealth on quality of life, behavior change, and health services utilization. His research on organizational change centers on models to understand and influence change and sustainability of change. The addiction treatment field is his primary test bed for these organizational change initiatives. Dr. Gustafson is a Fellow of the Association for Health Services Research and of the American Medical Informatics Association. He is a Fellow and past Vice–Chair of the Board of the Institute for Healthcare Improvement. He also chaired the Federal Science Panel on Interactive Communications in Health and chairs the board of the eHealth Institute. He is a member of the Institute of Medicine Committee on Redesigning Health Insurance Benefits, Payments and Performance Improvement Programs. He has received two awards from the University of Wisconsin for his humanitarian work.
Back to top

Constance M. Horgan, Sc.D. (Health Policy and Management, Johns Hopkins University), is a Professor at the Heller School for Social Policy and Management, Brandeis University and the founding Director of its Institute for Behavioral Health, which focuses on the intersection of health, behavior and systems of care. Dr. Horgan has focused her research on studying how behavioral health services are financed, organized, and delivered in the public and private sectors and what approaches can be used to improve the quality and effectiveness of the delivery system. She has over twenty-five years of experience in health policy analysis and services research in both academic and government settings. She has been involved with numerous national studies involving health surveys of both individuals and organizations, as well as extensive use of administrative data. She currently directs the Brandeis/Harvard Center on Managed Care funded by the National Institute on Drug Abuse (NIDA) and leads several other studies related to the delivery of alcohol, drug and mental health services. She also directs a National Institute for Alcohol Abuse and Alcoholism (NIAAA) doctoral training program in health services research and teaches courses in behavioral health and substance abuse policy. She has led studies for the Substance Abuse and Mental Health Services Administration (SAMHSA), Agency for Healthcare Research and Quality (AHRQ), National Institute of Mental Health (NIMH), NIDA, NIAAA, and foundations, including Robert Wood Johnson. Dr. Horgan has written numerous articles and served on expert panels and advisory committees for federal agencies, professional associations, and academic and community task forces.
Back to top


Jack Kemp, M.S. is the Director of Substance Abuse Services for the Division of Substance Abuse and Mental Health (DSAMH), the Single State AOD Agency (SSA) for the State of Delaware. In this position, Mr. Kemp is responsible for the management and administration of a statewide system of publicly funded alcohol and drug abuse prevention, early intervention and treatment programs. Kemp has over 34 years of experience in the field of addictions, mainly in senior management positions with the SSA’s in Delaware and New York. In addition to his current position in Delaware, he served as the Director of the Treatment Access Center (TASC), overseeing a statewide program that provided liaison between the substance abuse treatment and criminal justice systems. In New York, Mr. Kemp held a variety of management positions with the Office of Alcoholism and Substance Abuse Services (OASAS). In his current position in Delaware, Mr. Kemp redesigned and restructured the statewide substance abuse treatment system, and introduced a performance based contracting model that connects payment to performance. He served as Executive Leader for the Robert Wood Johnson/CSAT Network for the Improvement of Treatment (NIATx) State Pilot in Delaware to improve access and retention in treatment throughout the state and for the RWJF Advancing Recovery grant to implement evidence based practices. Mr. Kemp also is the Principal Investigator, in collaboration with the Treatment Research Institute, for a NIDA grant on Statewide Science-Based Concurrent Recovery Monitoring in Delaware. Mr. Kemp is a Board member of the National Association of State Alcohol and Drug Abuse Directors (NASADAD). He also is a member of the Washington Circle Policy and Public Sector committees. Mr. Kemp’s educational background includes an M.S. degree in Educational Counseling from the University of Scranton, and post-graduate training at the Alfred Adler Institute of Psychoanalysis in New York City. He is currently matriculated in the MALS (Master of Arts in Liberal Studies) graduate program at the University of Delaware.
Back to top


Carol McDaid serves as Principal at Capitol Decisions, Inc. (CDI), a firm she founded in May 2000 as one of the only public affairs groups in the nation’s capital with a specific focus on influencing federal alcohol and other drug (AOD) policy.  She brings to the firm nearly twenty-five years of federal legislative experience in Washington, D.C., representing business and nonprofit interests in health, employee benefit, telecommunications and related tax areas.  For over a decade, Ms. McDaid has worked with leading non-profit drug and alcohol treatment centers, pharmaceutical manufacturers, and other AOD prevention and consumer organizations to refine public policy addressing alcohol and other drug addiction.  She helps clients overcome the unique political challenges posed by the stigma associated with alcohol and drug addiction.  To break down these barriers, McDaid assists AOD clients in developing legislative and regulatory campaigns that overcome stigma by blending traditional lobbying techniques with public affairs strategies that highlight the societal benefits of recovery by using provocative personal stories of the transformational power of recovery to leverage the impact or influence an AOD client has over a regulatory, legislative, or industry issue.  These strategies combine traditional health care advocacy tactics with social marketing, third party constituency building, national media relations, Internet-based grassroots communications and identification and acquisition of federal funding in both the public and private sectors.  Ms. McDaid serves on the Betty Ford Institute Executive Council, the Caron Treatment Centers National Leadership Council and the Board of Directors for Faces and Voices of Recovery.  A North Carolina native, McDaid graduated from Emory University in Atlanta, Georgia, where she majored in political science.  The focus of her graduate work was in legislative affairs at George Washington University in Washington, D.C.
Back to top

Kay Miller is a Senior Research Leader at Thomson Healthcare in Santa Barbara with more than 26 years of experience with federal and state healthcare data. Her primary focus is working with administrative healthcare data as a project manager, programmer, analyst, and database designer. Through her participation on projects for SAMHSA, CMS, state Medicaid agencies, and related agencies, she has gained extensive knowledge of a wide variety databases. She has used this knowledge to assist in the development and testing of Washington Circle measures, both in the private sector and within state substance abuse agency systems. In addition, Ms. Miller has assisted in the creation of reports and analytic tables around such topics as psychotropic medication, cost and utilization of MH/SA services, children’s mental health, parity, and data integration and interoperability. She has provided technical assistance to states on data issues, including the design and implementation of integrated MH/SA and Medicaid data for reporting purposes. She was also instrumental in assisting CMS in the 1999 redesign of their Medicaid Statistical Information System. She offers an in-depth knowledge of healthcare data, ranging from claims and eligibility data systems to diagnosis and procedure coding systems. 
Back to top


Suzanne Gelber Rinaldo, Ph.D., the sociologist who is President of the Avisa Group, works extensively with Federal, State and county agencies on planning and evaluating the organization and financing of care and on barriers to evidence-based care and innovation, on behavioral health and chronic illnesses, including serious mental illness, addiction and chronic disease complicated by substance dependence. Dr. Gelber Rinaldo has done extensive analyses of issues with gender in treatment, on substance dependence and co-occurring mental illness and chronic disease and substance abuse treatment amongst men and women in criminal justice populations, on evaluation of small scale and large systems of treatment organizations and on evidence-based initiatives including national evaluations of screening and brief intervention and the buprenorphine waiver evaluation. She has worked on numerous national and state projects involving sensitive evaluations of the dissemination of evidence-based care and on the organizational designs that promote or inhibit the adoption of continuous quality improvement and innovative service delivery in behavioral health and physical health/chronic disease care. The Avisa Group has assisted numerous states and CA and other states’ counties, as well as health plans and the private sector to examine the issues, quality, key challenges and effectiveness of their behavioral health treatment systems, urban, suburban and rural.
Back to top


Richard Saitz, MD, MPH is a Professor of Medicine and Epidemiology, Fellow of both the American College of Physicians and the American Society of Addiction Medicine, Associate Director of the Office of Clinical Research, Director of the Clinical Addiction, Research and Education Unit, Associate Director of the NIH Youth Alcohol Prevention Center, and a primary care general internist and health services researcher. In the Office of Clinical Research he has led efforts to make a clinical data warehouse accessible to researchers, and to establish a research registry. He is a member of the University’s Research Compliance Advisory (to the Provost) Board, the General Clinical Research Center Advisory Committee, and the (research) Core Implementation & Oversight Committee. As CARE Unit Director, Saitz leads 8 faculty and 15 staff implementing substance abuse-related research and education projects. His primary areas of interest and expertise include screening and brief intervention for unhealthy alcohol and drug use, integrating substance-related and general health care (eg chronic disease/care management), and improving the quality of care for people with addictions across the spectrum of use particularly in general medical care settings. He is the author of over 70 peer-reviewed research publications that focus on unhealthy alcohol use in general healthcare settings. Dr. Saitz is President of the Association for Medical Education and Research in Substance Abuse, was Chairman of the Institutional Review Board at Boston University, and was selected as one of Ten Outstanding Young Leaders by the Boston Jaycees in 2003. He is a member of the Steering Committee of the international Motivational Interviewing Network of Trainers. His research has included randomized clinical trials, survey research, large database studies, and prospective cohort studies. He has had NIH, SAMHSA Center for Substance Abuse Treatment and Foundation support for his work (RWJF, as a Generalist Physician Faculty Scholar). Current support is from the NIH (PI of 2 R-01s, Co-PI of 2 R-01s, Co-I R-01, Co-Director K-30, Assoc-Dir P60, and PI of a R25). Dr. Saitz is currently PI of a randomized clinical trial testing outcomes associated with chronic disease management for alcohol dependence on in primary care, and of an effectiveness study of brief intervention for unhealthy alcohol use in hospitalized medical patients. He is also PI of a study testing the effects of a web-based intervention for unhealthy alcohol use in college students. He is Co-PI or Co-I for studies involving: effects of lifetime alcohol use using Framingham Heart Study data, a study of health utilities for patients with alcohol use, a study of an automated telephone intervention for problem alcohol use, and a study of the effects of alcohol on hepatitis C on HIV disease progression. Dr. Saitz has mentored 2 doctoral students, 8 junior faculty, and 11 fellows, he directs a unique program for resident physicians in clinical research as part of the K30, and is also the co-mentor for two faculty with K-23 awards and one junior faculty member with a RWJ career development award.
Back to top